Announcements Trials

Browse Landscape

Phase

Status

Unknown 5 Completed 4 Active not recruiting 2 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 14 Tumor-Agnostic 4 Genitourinary 4 Breast 3 Sarcoma 2 Gastrointestinal 2 CNS 2 Thoracic 1 Other solid neoplasm 1 Head & Neck 1

Conditions

SCLC,Extensive Stage 1

Interventions

Carboplatin 181 pembrolizumab 156 Pemetrexed 129 Cisplatin 97 Drug Therapy 67 Paclitaxel 59 osimertinib 56 Magnetic Resonance Spectroscopy 50 durvalumab 49 Specimen Handling 49 Radiotherapy 49 Nivolumab 49 atezolizumab 43 Docetaxel 43 Etoposide 40 Bevacizumab 39 Blood Specimen Collection 33 tislelizumab 31 Radiosurgery 31 Gemcitabine 29 130-nm albumin-bound paclitaxel 27 Immunotherapy 25 Immune Checkpoint Inhibitors 25 cemiplimab 23 Injections 23 aflutinib 20 Cetuximab 18 Biopsy 18 Standard of Care 17 Platinum Compounds 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × niraparib × Thoracic × Clear all

NCT05718323 2026-05-29

RAISE

ETOP IBCSG Partners Foundation

Phase 2 Recruiting

SCLC,Extensive Stage

Data powered by HemOnc (CC BY 4.0) Colophon ⚡